Jakavi 20mg Tablet (Ruxolitinib)

Overview:
Jakavi 20mg Tablet is a Janus kinase (JAK1/JAK2) inhibitor that works by blocking overactive enzymes involved in certain blood disorders, reducing abnormal blood cell production, and controlling inflammation. It is prescribed for patients with myeloproliferative disorders such as myelofibrosis and polycythemia vera.

Uses:

• Treatment of intermediate or high-risk myelofibrosis.

• Management of polycythemia vera in patients resistant or intolerant to hydroxyurea.

• Helps reduce spleen enlargement, control blood counts, and improve disease-related symptoms.

Dosage & Administration:

• Take exactly as prescribed by your hematologist.

• Usually taken twice daily with or without food.

• Swallow the tablet whole; do not crush, chew, or split.

• Regular blood counts and liver function tests are necessary during treatment.

Precautions:

• Inform your doctor if you have liver disease, kidney disease, low blood counts, or infections.

• Possible side effects include anemia, thrombocytopenia, bruising, dizziness, headache, or infections.

• Avoid live vaccines while on treatment.

• Use effective contraception during treatment.

• Store in a cool, dry place, away from light and moisture.

Why Choose Jakavi 20mg Tablet?

• Clinically proven JAK inhibitor therapy

• Reduces spleen size and disease symptoms effectively

• Helps control blood counts in myeloproliferative disorders

• Convenient oral tablet for daily dosing

Package Includes:

• Each pack contains 30 tablets of 20mg Jakavi (Ruxolitinib)